This report outlines how healthcare providers can take an active role in supporting the health of pregnant individuals who have opioid use disorder (OUD) and their babies. Key points include that buprenorphine and methadone can be safely used in pregnancy to treat OUD; medically supervised withdrawal from medications for OUD during pregnancy is not recommended; and there is a need for providers to prioritize health equity for underserved pregnant people with OUD.